RxDoctor Payments Data

Taylor Slagter

Family · Altoona, FLNPI 1427650530

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Boehringer Ingelheim at 28.2% of the total. 2025 is the largest year on record at $707, more than ten times the $11 reported in 2021.

$1,684in general payments, 2019–2025

Across 77 payments — averaging $21.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$475
  • Regeneron Healthcare Solutions, Inc.$226
  • GSK$140
  • Actelion Pharmaceuticals US, Inc.$136
  • Sanofi$97
  • United Therapeutics Corporation$78
  • plus $533 from 15 others

What the payments were for

  • Food & beverage$1,684100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,684 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Spiriva HandihalerTiotropium Bromide12$4,242

Paid to pharmacies, not to this prescriber.

Other family in Altoona

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →